Liang, Tao’s team published research in Journal of Medicinal Chemistry in 2020-10-22 | 20099-90-5

Journal of Medicinal Chemistry published new progress about Antitumor agents. 20099-90-5 belongs to class bromides-buliding-blocks, and the molecular formula is C9H7BrO3, Category: bromides-buliding-blocks.

Liang, Tao; Zhou, Yi; Elhassan, Reham M.; Hou, Xuben; Yang, Xinying; Fang, Hao published the artcile< HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells>, Category: bromides-buliding-blocks, the main research area is solid tumors HDAC Bax apoptosis antiproliferative cytotoxicity conformational activation.

Inspired by the synergistic effect of BTSA1 (a Bax activator) and SAHA (a histone deacetylase (HDAC) inhibitor) in HeLa cell growth suppression, a series of novel HDAC-Bax multiple ligands were designed rationally. Compound 23, which possesses similar HDAC inhibitory activity relative to SAHA and Bax affinity comparable to BTSA1, exhibits a superior growth suppression against HeLa cells, and its antiproliferative activities are 15-fold and 3-fold higher than BTSA1 and SAHA, resp. The better antiproliferative activity and lower cytotoxicity of compound 23(I) indicated that our HDAC-Bax multiple ligand design strategy achieved success. Further studies suggested that compound 23 could enhance Bax-dependent apoptosis by upregulating Bax, followed by inducing the conformational activation of Bax. To our knowledge, we first report HDAC-Bax multiple ligands and demonstrate a new paradigm for the treatment of solid tumors by enhancing Bax-dependent apoptosis.

Journal of Medicinal Chemistry published new progress about Antitumor agents. 20099-90-5 belongs to class bromides-buliding-blocks, and the molecular formula is C9H7BrO3, Category: bromides-buliding-blocks.

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary